Rick Jordan is a trusted advisor who delivers prompt business-oriented advice to his national client base.

Rick advises private equity, growth equity, venture capital, and other investment funds, as well as companies focused on an array of industries. Rick’s full-service team supports clients focused on biotech/life sciences, consumer goods, innovative technology, AI, Web3, fintech, healthcare, real estate, industrial products, energy, manufacturing, construction and hospitality. Rick serves as Co-Chair of Polsinelli’s Venture Capital practice.

Rick’s experience covers a broad spectrum of corporate and governance matters. On the transactional side, Rick and his team regularly handle early- and late-stage equity financings (representing investors and issuers), sponsor-led minority investments and control acquisitions/dispositions.

In addition to managing day-to-day governance, commercial, employment, intellectual property, tax and other work, Rick’s team also handles other complex matters, such as bolt-on acquisitions, corporate venture investments, joint ventures, restructurings and licensing deals. The team also structures innovative liquidity solutions for equity holders in later-stage growth companies.

Rick regularly serves both public and private companies and acts as outside general counsel for several prominent businesses.

Rick’s clients include:

  • Private equity, growth equity, venture capital and other investment funds
  • Family offices and independent sponsors
  • Public and private companies (including portfolio companies)
  • Boards of directors and board committees
  • C-Suite management teams
  • Investors (angel and later stage)
  • High-growth potential businesses and entrepreneurs

A long-time Dallas native, Rick has a strong interest in supporting healthy/active lifestyle pursuits. He co-founded and is active in DFW CPG, a community for consumer products enthusiasts. Rick recently relocated his family to Park City, Utah where, among other things, he supports U.S. Ski & Snowboard and serves as a founding member on its NextGen Leadership Board. 

Education

  • Texas A&M University (B.S.)
    • Southern Methodist University Perkins School of Theology (M.T.S.)
      • Southern Methodist University Dedman School of Law (J.D.)

        Bar Admission

        • Texas
        • Utah

        Professional Affiliations

        • State Bar of Texas
          • Business Law Section
            • Emerging Business/Venture Capital Committee Chair, 2015-2022
            • Member, Leadership Council, 2018-Present
            • Treasurer and Secretary, 2014-2015
            • Contracts Committee Co-Chair, 2014-2015
        • Dallas Bar Association
        • Dallas Association of Young Lawyers
        • Texas Venture Capital Association
        • Texas Business Law Foundation
          • Secretary-Treasurer, 2016-2018

        Recognition

        • Ranked in Chambers USA: America’s Leading Lawyers for Business, Startups & Emerging Companies, Nationwide, 2025
        • Selected for inclusion in Best Lawyers in America® for Mergers and Acquisitions Law, 2022-2026
        • Selected by The American Lawyer as a South Trailblazer, 2022
        • Named a "Legal Innovator" by Texas Lawyer Magazine, 2020
        • Named "Texas Rising Star" by Super Lawyers for Mergers & Acquisitions, 2013-2020
        • Named "2019 Rising Star" by D Magazine, 2019
        • Named "Who's Who in Impact Investing", Rocky Mountain Impact Investing, 2018
        • Selected for inclusion in Best Lawyers Under 40 by D Magazine, 2018-2019
        • Selected for inclusion in Best Lawyers in Dallas by D Magazine for:
          • Corporate Law: Private Equity, 2017, 2021
          • Corporate Law: Mergers & Acquisitions, 2018
          • Corporate Securities/Capital Markets, 2012-2014
        Publications
        Polsinelli Life Sciences Spotlight - Volume 3 - Turning Insight into Action: A Life Sciences Playbook for 2026
        We are pleased to share Volume 3 of our Life Sciences Spotlight: Turning Insight into Action: A Life Sciences Playbook for 2026. We look back at a year defined by resilience and ahead to one shaped by opportunity. From M&A readiness and FDA reform to AI-driven innovation and enforcement risk, this edition delivers practical guidance for navigating what’s next. M&A-Ready from Day One Reshaping the FDA: 2025’s Key Trends and the 2026 Outlook Fraud & Abuse Enforcement in the Life Sciences: The Year In Review From Scattered Logs to Connected Insight: How Eschbach is Transforming Frontline Documentation in Life Sciences When Biology Meets Computing: The Patent Challenges of Bioinformatics University Tech Transfer in Transition: Highlights from Polsinelli’s Life Sciences Tech Transfer Office Roundtable Practical Strategies for Drug Labeling Amendments 
        Read More
        Polsinelli Life Sciences Spotlight - Volume 2 - Adapting by Design: Navigating Complex Times in Life Sciences
        We are pleased to share Volume 2 of our Life Sciences Spotlight report: Adapting by Design: Navigating Complex Times in Life Sciences. In today’s evolving landscape, companies must be prepared to meet complexity with clarity and agility. This edition explores the strategies, insights and innovations enabling industry leaders to adapt — with purpose: Pharma Tariffs are Coming - Are You Ready? End of Lifecycle Challenge for Biologics: How to Avoid the Pitfalls Near the End of Exclusivity Q&A with VivoSim CEO Keith Murphy The Rising Threat of Brand Abuse — and How Life Sciences Companies Can Respond PFAS Regulations Impacting the Life Sciences Industry BIO Week in Boston: Highlights & Takeaways  Join Us During Biotech Week Boston 2025  Explore the full report to see what’s shaping the future and
        Read More